Category: Harm Reduction

  • Harm Reduction and the Public Good in Victoria, BC

    Harm Reduction and the Public Good in Victoria, BC

    It seems that in Canada, public meetings about harm reduction bring out the best and worst in people. This was certainly the case on Wednesday at a public meeting to discuss the inclusion of improved services in a local health unit on the edge of Victoria’s Fernwood neighbourhood.

    This location is already the site of Victoria’s Sobering Centre and its Medical Detox facility. The meeting was held at the initiation of the Vancouver Island Health Authority (VIHA) to discuss their plan to create two service hubs in Victoria for harm reduction services. As you may recall, Victoria was forced to close its only fixed site needle exchange in 2008 after controversy erupted over public congregation outside its doors. Since then, attempts to move this site to other locations have been met with vociferous public opposition despite an intentional shift away from having just one location to having over 20 options for accessing needles and supplies.

    Going in to the meeting, no one was happy. Clearly some thought the proposed services were too little and some though they were too much. Supporters of people who use drugs wondered about the inclusion of peers in the development and implementation of these services. But some area residents seemed palpably angry about VIHA’s new plan. The Health Authority took pains to argue that their latest proposal only adds new professional services to two locations already providing harm reduction supplies. But no matter how much reassurance representatives gave, some residents still angrily denounced the service.

    Their language was pointed and painfully discriminatory – “those people”, “them” – meaning people who use drugs. Some neighbours worried about the safety of their children and some were afraid that violence, property theft and damage would escalate in their community. Even a Victoria Police’s Staff Sergeant Dave Bown challenged these speakers to rethink that one. These same neighbours were angry with VIHA for communicating their plans in the media despite an agreement to consult with neighbours.

    These days, community input into health care can be an afterthought and even VIHA representatives admitted last night that that they could have done a better job of getting feedback on the plans from residents. So the neighbours are probably angry for a reason. But still, the opposition to harm reduction reminded me that it’s easy to pit children’s safety against the needs of a scary “other”. It’s much harder to get down to work on making the community safe for all, including people who use drugs.

    These kinds of public meetings are taking place all over Canada as residents oppose proposed harm reduction or methadone services in their neighbourhoods. And media coverage often goes hand-in-hand with these events – conveying partial truths and giving angry voices the opportunity to parade out the worst of discriminatory attitudes toward people who use drugs.

    At the same time, I was heartened by some of last night’s speakers who invited their neighbours to help clean up used needles and offered examples of successful programs to educate children about harm reduction. Some neighbours repeatedly spoke about their fear of discarded needles until one resident of Fernwood, Andrea Langlois, stood up and reminded everyone that no one had ever contracted HIV from being poked by a inappropriately discarded syringe off the street. That turned the tide and other neighbours stepped forward to praise the plan and welcome the services. A couple of speakers even wondered if public use of drugs could be addressed with supervised consumption services. These weren’t people used to speaking the language of harm reduction but they seemed to get it – that the public safety and health of the whole community is enhanced by a full range of harm reduction services.

    One of the final speakers from the audience capped off the evening with a request that many of us could heed – stop sowing the seeds of fear and get to work on meeting the needs of all our citizens.

  • Cheap, Easy, and Lifesaving—Naloxone Treatment for Overdose

    Cheap, Easy, and Lifesaving—Naloxone Treatment for Overdose

    How much does it cost to save a life? That question got a clear and striking answer this week in the case of overdose from heroin in the United States. A study published in the Annals of Internal Medicine found that distribution of the overdose antidote naloxone—a safe, non-abusable, and inexpensive medicine—to one in five heroin users in the United States could prevent as many as 43,000 deaths. The cost of distribution would be equivalent to some of the cheapest, most effective, and most accepted medical interventions, like checking blood pressure at a doctor’s office.

    The study used mathematical modeling to assess whether giving out naloxone was “worth it”—that is, to determine how much naloxone distribution would cost per “quality-adjusted” year of life gained. This is the measure used by economists and policymakers to compare health interventions and decide which ones are affordable. The naloxone study also investigated assumptions that patient advocates would rather not acknowledge—like whether it would be cheaper to let illegal drug users die, or to put them in jail. Those are ugly questions, but ones that certainly run through the minds of opponents of health services for drug users worldwide. The answer was that naloxone saves lives with costs far below what health or prison systems pay. For example, screening for cancer with colonoscopy costs over $50,000 per quality adjusted life year gained in the United States, and screening for HIV costs around $40,000.

    Naloxone distribution saves lives for as little as $400.

    The other question, of course, is whose lives are deemed worth saving. Drug overdose now kills more adults a year in the United States than motor vehicle accidents, or deaths from choking or accidental falls. Most of us have seen safety messages related to driving, choking, or minding our step, but naloxone and other measures to prevent overdose remain unknown to many at risk. As noted in an editorial in the same journal, co-authored by officials from the National Institute on Drug Abuse and the FDA, making new and easy-to-use formulations of the medicine can help. However, action can be taken now to make the medicine available to heroin users—actions that will prevent thousands of needless deaths, and spare family and friends who may have to watch helplessly as their loved ones stop breathing.

    – Daniel Wolfe

    Daniel Wolfe is director of the International Harm Reduction Development Program at the Open Society Foundations. This blog post was originally published on the Open Society Foundations website.

  • Drug Policy Leaders Honoured with Diamond Jubilee Award

    Drug Policy Leaders Honoured with Diamond Jubilee Award

    At an event to be held at Simon Fraser University’s Harbour Centre Campus this evening, Senator Pierre Claude Nolin will award sixteen individuals from British Columbia’s drug policy reform community with the Queen’s 60th Anniversary Diamond Jubilee Medal.

    Among the recipients are the Canadian Drug Policy Coalition’s Executive Director, Donald MacPherson, and steering committee members Philippe Lucas and Gillian Maxwell.

    “All of these recipients have worked to improve public health in their community. They have dedicated many years of their lives to participate in the implementation, evaluation and construction of programs to help those struggling with addictions or health issues to connect with the services and medication they need,” said Senator Nolin. “They have worked with municipal, provincial and federal governments to advance critical public health programs, and such work is indispensable to our nation as a whole.”

    In lieu of the Senator’s absence due to medical appointments, the event will be presided over by Philip Owen, former Mayor of Vancouver, and Senator Yonah Martin, who will present the medals.

    The event will also feature a special tribute to Irene Goldstone, former Director, Professional Education and Care Evaluation at the BC Centre for Excellence in HIV/AIDS.

    Full list of recipients:

    Donald MacPherson, Bud Osborn, Liz Evans, Dean Wilson, Maxine Davis, Gillian Maxwell, Ann Livingston, Philippe Lucas, Rielle Capler, Kirk Tousaw, John Conroy, David Bratzer, Dr. Evan Wood, Dr. Thomas Kerr, Hilary Black, Mark Haden.

  • The Insite Story: Transforming Health Care Services through Leadership, Risk Tolerance and Innovation

    The Insite Story: Transforming Health Care Services through Leadership, Risk Tolerance and Innovation

    It has been said that “an essential aspect of creativity is not being afraid to fail.” A PricewaterhouseCoopers’ survey conducted among the Times 1000 leading companies found that one of the common characteristics among the most innovative companies is that they take a balanced view of risk-taking behaviours. But a recent Conference Board of Canada survey conducted among Canadian health care executives confirmed that Canadian health care leaders have low tolerance for risk. Boards are perceived to be more risk-averse than executive teams by a fairly wide margin. As seen in the chart below, 57 per cent of respondents agreed or strongly agreed that their executive teams are risk-tolerant, compared to the 37 per cent who agreed or strongly agreed that their boards are risk tolerant, a difference of 20 points.

    blog-121812-2At a recent meeting of the Centre for the Advancement of Health Innovations in Vancouver, Insite, North America’s first legal supervised injection site for drug users, exemplified the importance of adopting a balanced approach towards risks. Insite’s leaders have taken bold actions, many of which carried significant risks, to implement innovative and transformative health care services.

    Insite was created to provide needed services to a population group that has suffered social stigma, abuse and social exclusion in Canada: drug-addicts. Before Insite, there were very few effective solutions to protect drug users from HIV and drug overdose but Insite has changed this reality.It offers clean injection supplies, withdrawal management support, detoxification areas and transitional recovery housing. A team of mental health workers, counsellors, nurses and physicians work with people with drug addiction to educate, intervene when necessary, plan a path to recovery and assist with re-integration in the wider community.

    And the results are outstanding: thirty-three per cent of Insite users are more likely to go to detox if they use the site once a week; 70 per cent are less likely to report syringe sharing, thus reducing HIV risk behaviour; and fatal overdoses within 500 metres of Insite decreased by 35 per cent after the facility opened compared to a decrease of 9 per cent in the rest of Vancouver. The benefits also extend to the heath care system and society: it has been estimated that supervised injection can save $14 million and 920 life years over 10 years due to a reduction in HIV, hepatitis and other medical interventions.

    Despite these proven benefits, Insite has had to fight legal battles to prove legitimacy. In 2006, the federal government deferred the decision to extend Insite’s special exemption from the Controlled Drugs and Substances Act, citing a lack of evidence to support the benefits of supervised injection. In a brave demonstration of leadership, Insite’s supporters took the matter to the Supreme Court of Canada, which in 2011, ruled unanimously to uphold Insite‘s exemption, allowing the facility to stay open indefinitely. Over the past nine years, more than one million injections have taken place at Insite under supervision and with clean equipment. It is the busiest supervised injection site in the world with over 1,200 visits every day.

    Insite’s leaders did not run away or gave up on their vision when the many obstacles appeared; they relentlessly focused on implementing change and appropriately and effectively managing the risks associated with a program of this nature. And these efforts have paid off: by partnering with the local health authority, Insite has been able to effectively bringing innovative health care services to marginalized populations who were previously unreachable.

    The program continues to work with low-income people to bring more opportunities for this hard-to-reach population to control their addictions and access effective, culturally appropriate chronic disease management and disease prevention programs. Insite’s daring leaders were not paralyzed by fear of failure. They are transforming health care services by demonstrating that the “best health care solution lies in treating all people humanely”.

    – Jeannette Lye

    Jeannette is a graduate of the School of Public Administration at Dalhousie University and in addition holds a Master of Science in Cultural Psychology from Brunel University and an undergraduate degree in psychology from Acadia University. This blog post was originally published on ConferenceBoard.ca

  • Breaking the Taboo

    Breaking the Taboo

    The CDPC is proud to join together with the Beckley Foundation, Virgin Unite, Sundog Pictures, Avaaz.org, The Global Commission on Drugs, and civil society NGO’s from around the world in calling for a fundamental review of global strategies in response to drugs.

    Breaking the taboo is a bold new international challenge. At the heart of the initiative is a groundbreaking documentary film that uncovers the UN sanctioned war on drugs, charting its origins and its devastating impact on countries like the USA, Colombia and Russia. Narrated by Morgan Freeman and featuring prominent statesmen including Presidents Clinton and Carter, the film follows The Global Commission on Drug Policy on a mission to break the political taboo and expose the biggest failure of global policy in the last 50 years.

    www.breakingthetaboo.info

    We encourage you to get involved, read the Beckley Foundation letter, sign the AVAAZ Campaign, and join the conversation on twitter using the hashtag #breakingthetaboo.

    Global commissioner on drug policy Richard Branson hopes “this film will open people’s eyes on the war on drugs and the failed war on drugs and make it easier for people who want to be brave and do something about it.” Among those featured are Colombian president Juan Manuel Santos and former US president Bill Clinton, who admits bluntly that the US-led war on drugs in Colombia “hasn’t worked”. Clinton also talks about the need for rehabilitation rather than incarceration when dealing with people with addictions. Sir Richard said countries such as Portugal and Spain, where drug users receive treatment rather than being jailed, provide a template. He believes that legalisation of cannabis is “inevitable”. “I have hardly ever come across a politician that won’t say – off the record – what needs to be done … in the end they just need to be brave,” he said.

  • Coalition Spotlight: Canadian HIV/AIDS Legal Network

    Coalition Spotlight: Canadian HIV/AIDS Legal Network

    The HIV epidemic is one of the most crucial public health issues of our time. What at one time seemed to be an insurmountable challenge has been abetted by education, research, innovation, and an immeasurable amount of hard work. The tools to curb the spread of HIV and improve the lives and health of those living with the disease are now more widely available, but the possibility of fostering an AIDS-free generation still faces a number of obstacles, most of which relate to unrealized human rights, access to medicine, harm reduction, and unjust laws.

    One of most prolific groups working on solving the problems that are currently hindering the fight against HIV/AIDS is the Toronto-based Canadian HIV/AIDS Legal Network. Celebrating its 20th year of operations this December, the Canadian HIV/AIDS Legal Network is Canada’s leading advocacy organization dedicated to legal and human rights issues related to HIV/AIDS. The network’s mission is to promote the human rights of those living with and vulnerable to HIV/AIDS, in Canada and abroad, through research and analysis, advocacy and litigation, public education and community mobilization.

    One such issue that the Legal Network is currently working on is the matter of syringe exchanges in Canadian prisons. Syringe exchange is critical to any comprehensive strategy to prevent the spread of infectious diseases, but the distribution of sterile injection equipment is not currently permitted within any Canadian prison — despite the overwhelming evidence of the benefits of prison-based needle and syringe programs (PNSPs) around the world

    To challenge this policy, the Canadian HIV/AIDS Legal Network, along with Prisoners with HIV/AIDS Support Action Network (PASAN), CATIE, the Canadian Aboriginal AIDS Network (CAAN) and Steven Simons, a former federal prisoner, launched a lawsuit on September 25th against the Government of Canada over “its failure to protect the health of people in prison through its ongoing refusal to implement clean needle and syringe programs to prevent the spread of HIV and hepatitis C virus (HCV) in federal institutions.”

    Rates of HIV and hepatitis C among Canadian prisoners are 10 to 30 times higher to that of the overall population. Although illicit drug use is strictly prohibited within correctional facilities, its prevalence is an undeniable fact.

    While the question of giving prisoners access to clean injection equipment might at first glance seem counterintuitive, it’s actually quite straightforward given the evidence that PNSPs benefit prisoner health, and in turn, the public health at large.

    For more information on the court case and PNSPs, visit the Canadian HIV/AIDS Legal Network’s website for the campaign – Prison Health Now.

    In addition to matters directly related to drug policy such as PNSPs, the Canadian HIV/AIDS Legal Network deals with issues such as discrimination, Aboriginal communities, women’s rights, sex work, income security, and so forth (click here for a complete list).

    Other current campaigns and activities include:

    Positive Women: Exposing Injustice

    A 45-minute documentary film that tells the personal stories of four HIV-positive women, “Positive Women Exposing Justice” explores the reality of the criminalization of HIV non-disclosure in Canada. For more information, visit the film’s website.

    HIV Non-Disclosure and the Criminal Law

    On October 25th, the Legal Network released several publications analyzing two recent Supreme Court rulings on cases of HIV non-disclosure. A summary of the decisions and a longer analysis are available here.

    Making Good on Canada’s Pledge: Affordable Medicines for All

    For many years, the Legal Network has spearheaded a global campaign to reform Canada’s Access to Medicine Regime (CAMR), which would allow Canada to ensure greater access to affordable, generic medicines for AIDS and other health issues in developing countries. Central to this campaign is Bill C-398, which if passed will fix and streamline CAMR, allowing medications to get to those most in need.

    For more information on Bill C-398, visit the Canadian HIV/AIDS Legal Network Medicines for All website.

    On December 4, 2012, at 7:00 p.m., philanthropists, funders, members, community organizations, people living with HIV/AIDS, and allies will gather at the Law Society of Upper Canada (Convocation Hall) in Toronto to celebrate the Canadian HIV/AIDS Legal Network and honour the recipients of the 2012 Awards for Action on HIV/AIDS and Human Rights. Click here for more information on the event.

    The Canadian HIV/AIDS Legal Network is a Canadian Drug Policy Coalition partner in change, working towards a better drug policy for Canada based on evidence, human rights, social inclusion and public health.

  • Bud Osborn: Drug War Poems & DTES history

    Bud Osborn: Drug War Poems & DTES history

    Bud Osborn’s prose charges drug policy debates with deep revelations and compassion. As a long time poet and social activist living in Vancouver’s Downtown Eastside, Bud is a light for many. His evidence is wrapped in poetry that can only come from first hand experiences. He turns the suffering he sees into poignant words aimed at shattering the paradigm of prohibition.

    At an epicenter of the war on drugs in Canada, the residents of the Downtown Eastside have long known the harms of prohibition. On September 22, 2012 the community gathered under a tent at Oppenheimer park for a day of open dialogue and discussion and food. After the acknowledgment and welcoming to Coast Salish Territory, Bud opened the day with this poem on the drug war and the story of the neighborhood. Please share this video and let his words inspire more discussion and change. Together we can build a future of collective self-determination and social justice.

  • Envy and Love in Portland

    Envy and Love in Portland

    Is it possible for a Canadian interested in issues like scaling-up harm reduction and drug law reform to envy the U.S.? That’s the worrisome question that crossed my mind as I sat in the opening plenary of the 9th National Harm Reduction Conference in Portland, Oregon.

    Two U.S. states recently voted to pass ballot initiatives that would end the prohibition of cannabis use by adults. And in the spirit of dignity, law reform and harm reduction activists have championed a myriad of community-based and public health department-led initiatives to scale-up overdose prevention and response programs. That reality is evident here in Portland, given the number of sessions devoted to this topic. Speakers like Willie Dudley of Casa Segura in Oakland, CA, talked about the empowerment experienced by peers who’ve been trained to respond to overdoses with the opiate agonist Naloxone.

    And then there’s Gil Kerlikowske. He’s the head of the White House’s Office on National Drug Control Policy. Given the recent U.S. election outcome, it looks like he gets to keep his job as Obama’s drug Czar. Typically that office has championed the war on drugs and all its brutality, but Kerlikowske delivered welcoming remarks to the delegates in Portland via video feed. He took pains to note that he was the first person in his position to do so. Likely his appearance at this conference is the result of the hard work of relationship building done by people like Allan Clear, head of the New York-based Harm Reduction Coalition. Kerlikowske reiterated his support for syringe exchange and echoed the commitment made by his office this past summer to support the scale-up of overdose programs including making Naloxone more readily available.

    Of course rhetoric is one thing and reality is another. Behind Kerlikowske’s words is still the reality of the U.S.-led war on drugs, which includes American support for the militarization of the drug war along the Mexico/U.S. border. There’s still a federal ban on funding for syringe distribution re-imposed by a Republican controlled congress in 2010. And there are still thousands of arrests daily for drug possession. One need only to turn briefly to Michelle Alexander’s book, The New Jim Crow, to be astutely reminded that this drug war is a racist one. But then again, these realities are also true in Canada where First Nations people are disproportionately imprisoned, where Canada also supports the militarization of the U.S./Mexico drug war and where harm reduction has been redlined in the National Anti-Drug Strategy.

    Yes it’s true that we have deep political resistance to harm reduction in Canada but nevertheless we must figure how we can work together across the country to scale-up harm reduction services. We can’t keep it secret anymore. The proponents of harm reduction have created a profoundly important practice of health engagement and we have something to teach the rest of the system. So let’s get that conversation going. If you’ve already started, let us know what works best and we will share that wisdom with everyone who will listen.

  • Reporting on Canadian Drug Policy

    Reporting on Canadian Drug Policy

    The CDPC is in the process of preparing a report on Canadian drug policy. Due out this winter in advance of the next meeting of the International Narcotics Control Board, this report will assess the state of Canada’s drug policy frameworks using a public health, social inclusion and human rights lens.

    In Canada, as in most other places in the world, the best-funded response to problems associated with drug use has been to increase law enforcement efforts, resulting in the incarceration of increasing numbers of people who use drugs.

    Our critical assessment of policy frameworks will reveal the extent to which our governments are committed to effective policies that prevent and reduce harms associated with alcohol, tobacco and other drugs and seek alternatives to criminalization.

    This report will provide the baseline data for future reports on drug policy in Canada and it will be a cornerstone in the Coalition’s advocacy work. The CDPC is seeking your help with this project. If you have any information you would like to share about your organization or your experience with drug policy in Canada, or if you want more information about this project, please contact Connie Carter, Senior Policy Analyst, by email at [email protected].